septemb
novel
lineag
c
betacoronaviru
identifi
etiolog
agent
caus
sever
respiratori
infect
human
middl
east
novel
viru
formal
name
middl
east
respiratori
syndrom
coronaviru
merscov
coronaviru
studi
group
intern
committe
taxonomi
virus
septemb
merscov
caus
infect
case
death
countri
worldwid
high
casefat
continu
mer
epidem
middl
east
believ
relat
failur
control
zoonot
sourc
probabl
dromedari
camel
result
ongo
cameltohuman
transmiss
primari
case
mer
epidemiolog
link
middl
east
numer
cluster
commun
healthcar
set
also
report
largest
healthcareassoci
outbreak
occur
republ
korea
case
includ
death
occur
index
patient
return
middl
east
high
casefat
rate
mer
capabl
merscov
caus
outbreak
healthcar
facil
pose
signific
threat
public
health
worldwid
unlik
humanpathogen
coronavirus
mainli
caus
selflimit
upper
respiratori
tract
infect
merscov
capabl
caus
sever
diseas
lower
respiratori
tract
involv
extrapulmonari
manifest
patient
sever
mer
often
present
pneumon
symptom
includ
fever
cough
dyspnea
progress
respiratori
failur
acut
respiratori
distress
syndrom
extrapulmonari
manifest
renal
failur
hepat
dysfunct
diarrhea
uncommon
addit
derang
coagul
profil
hematolog
chang
may
also
observ
sever
mer
infecti
viru
could
recov
exclus
patient
respiratori
tract
whilst
viral
rna
could
detect
extrapulmonari
specimen
blood
urin
stool
nucleic
acid
amplif
test
clinic
laboratori
find
suggest
possibl
dissemin
viral
infect
mer
bear
resembl
sever
acut
respiratori
syndrom
sar
term
clinic
manifest
etiolog
agent
sar
lineag
b
betacoronaviru
sar
coronaviru
sarscov
sarscov
infect
patient
casefat
rate
affect
countri
worldwid
howev
unlik
sar
autopsi
studi
conduct
deceas
mer
patient
therefor
understand
pathogenesi
mer
remain
larg
elus
review
summar
current
knowledg
merscov
cellular
tropism
virushost
interact
observ
vitro
human
cell
ex
vivo
human
tissu
implic
pathogenesi
mer
relev
find
merscov
infect
experiment
anim
also
review
aim
recapitul
human
mer
diseas
better
understand
pathogenesi
human
merscov
infect
primari
infect
site
mer
human
respiratori
tract
demonstr
merscov
could
effect
infect
robustli
replic
human
airway
epithelium
ex
vivo
tissu
human
respiratori
tract
also
examin
cellular
tropism
merscov
shown
merscov
infect
noncili
bronchial
epitheli
cell
bronchiolar
epitheli
cell
alveolar
epitheli
cell
endotheli
cell
pulmonari
vessel
addit
upon
merscov
infect
ex
vivo
lung
tissu
uninfect
cell
underw
massiv
apoptosi
extens
caspas
activ
implic
paracrin
mechan
may
contribut
induct
apoptosi
anoth
studi
human
ex
vivo
lung
tissu
echo
discoveri
merscov
product
infect
replic
well
occurr
infectioninduc
apoptosi
human
lung
tissu
moreov
shown
merscov
infect
ex
vivo
lung
tissu
display
compar
extent
kinet
infect
highli
pathogen
avian
influenza
viru
lung
tissu
donor
indic
high
infect
merscov
human
respiratori
epithelium
howev
latter
studi
merscov
could
also
infect
ciliat
bronchial
epitheli
cell
cell
suscept
viru
former
studi
notabl
studi
human
ex
vivo
airway
tissu
invari
reveal
pulmonari
endotheli
cell
highli
suscept
merscov
suggest
merscov
infect
respiratori
tract
could
potenti
develop
systemat
dissemin
infect
taken
togeth
human
respiratori
epithelium
highli
permiss
merscov
effect
infect
result
robust
viral
propag
massiv
induct
apoptosi
studi
provid
patholog
basi
major
pulmonari
featur
mer
ie
pneumonia
acut
lung
injuri
first
line
host
defens
human
epitheli
cell
stimul
produc
antivir
proinflammatori
cytokin
chemokin
elimin
invad
pathogen
base
studi
human
primari
respiratori
epitheli
cell
respiratori
epitheli
cell
line
ex
vivo
human
lung
tissu
consensu
recognit
induct
antivir
interferon
ie
type
iii
ifn
basic
dampen
although
type
type
iii
ifn
treatment
effect
inhibit
merscov
replic
addit
merscov
infect
fail
elicit
strong
proinflammatori
cytokin
respons
human
primari
respiratori
epitheli
cell
ex
vivo
respiratori
tissu
respiratori
epitheli
cell
line
cell
use
studi
earli
late
phase
innat
immun
respons
merscov
infect
demonstr
proinflammatori
cytokineschemokin
exhibit
delay
mark
induct
upon
merscov
infect
base
observ
antagonist
mechan
merscov
attenu
innat
immun
respons
extens
sought
number
merscov
protein
includ
papainlik
proteas
membran
protein
accessori
protein
identifi
suppress
interferon
product
among
merscov
shown
suppress
pactinduc
activ
rigi
circumv
innat
immun
respons
addit
merscov
papainlik
proteas
exhibit
deubiquitin
deisgyl
activ
suppress
innat
immun
respons
collect
merscov
may
evolv
multipl
antagonist
mechan
dampen
attenu
host
defens
contribut
high
pathogen
human
consist
respons
merscov
interferon
treatment
vitro
combin
treatment
ribavirin
reduc
viru
replic
improv
clinic
outcom
merscov
infect
rhesu
macaqu
demonstr
treatment
show
better
outcom
virusinocul
common
marmoset
novel
merscov
broad
tissu
cellular
tropism
includ
human
monocyt
cell
line
subsequ
studi
focus
human
macrophag
demonstr
merscov
could
effici
infect
replic
human
monocytederiv
macrophag
mdm
notabl
increas
viral
rna
consist
detect
merscov
infect
mdm
deriv
differ
donor
within
h
post
infect
addit
merscov
significantli
induc
express
proinflammatori
chemotact
cytokin
chemokin
includ
infect
human
macrophag
meantim
merscov
trigger
upregul
mhc
class
mhc
class
ii
costimulationrel
gene
mdm
furthermor
util
ex
vivo
organ
cultur
author
demonstr
alveolar
macrophag
human
lung
tissu
suscept
merscov
sarscov
infect
human
macrophag
howev
viral
replic
sarscov
human
macrophag
abort
infecti
viru
particl
produc
despit
abort
infect
sarscov
infect
human
macrophag
induc
express
number
proinflammatori
chemokin
includ
hand
induct
import
antivir
cytokin
key
compon
innat
immun
larg
absent
dendrit
cell
essenti
sentinel
immun
system
detect
invad
pathogen
bridg
innat
immun
system
adapt
immun
system
infect
human
monocytederiv
dendrit
cell
mdc
merscov
product
evidenc
progress
increas
viral
antigen
express
increas
viral
rna
increas
viru
titer
cultur
media
infect
cell
intriguingli
studi
author
report
merscov
induc
margin
express
infect
dendrit
cell
hand
merscov
trigger
substanti
express
significantli
higher
sarscovinfect
dendrit
cell
addit
surfac
express
mhc
class
ii
costimulatori
molecul
disturb
merscovinfect
dendrit
cell
might
contribut
immun
dysregul
merscov
infect
recent
scheuplein
et
al
report
infect
plasmacytoid
dendrit
cell
merscov
remark
author
conclud
although
merscov
infect
plasmacytoid
dendrit
cell
abort
infect
induc
product
larg
amount
type
type
iii
ifn
exclus
cell
case
sarscov
number
studi
demonstr
human
dendrit
cell
suscept
sarscov
unabl
support
viral
replic
nonetheless
sarscov
infect
led
phenotyp
function
matur
dendrit
cell
regard
mhc
class
ii
costimulatori
molecul
express
cellstimulatori
capac
cytokinechemokin
product
includ
importantli
zhao
et
al
demonstr
potenti
role
dendrit
cell
control
pathogenesi
sarscov
mous
studi
particular
author
show
sever
outcom
sarscov
infect
correl
slow
kinet
viru
clearanc
delay
activ
respiratori
dendrit
cell
collect
contrast
inabl
elicit
product
proinflammatori
cytokin
human
respiratori
epitheli
cell
merscov
sarscov
abl
stimul
induct
proinflammatori
cytokineschemokin
human
macrophag
dendrit
cell
howev
question
aris
whether
trigger
innat
immun
respons
benefici
detriment
merscov
sarscov
infect
patient
sinc
host
immun
respons
may
act
twoedg
sword
differ
stage
diseas
therefor
studi
warrant
experiment
anim
patient
elucid
virushost
interact
immun
cell
affect
pathogenesi
human
coronaviru
infect
although
lymphopenia
commonli
observ
sar
mer
patient
exact
caus
lymphopenia
current
remain
unknown
postul
sarscov
may
directli
infect
cell
lead
cell
deplet
howev
altern
model
lymphopenia
upon
sarscov
infect
also
propos
includ
sequestr
lymphocyt
within
inflam
tissu
cytokineinduc
cell
death
well
suppress
hematopoiet
progenitor
cell
bone
marrow
thymu
infect
merscov
recent
studi
demonstr
infect
human
celldefici
mice
merscov
result
persist
merscov
lung
viru
clear
control
mice
b
celldefici
mice
find
hint
cell
might
play
critic
role
control
pathogenesi
merscov
subsequ
studi
publish
earlier
year
directli
address
issu
merscov
infect
cell
author
demonstr
cell
human
peripher
blood
mononuclear
cell
human
lymphoid
tissu
spleen
common
marmoset
highli
suscept
merscov
furthermor
merscov
induc
substanti
apoptosi
infect
cell
involv
activ
intrins
extrins
caspasedepend
apoptosi
pathway
result
suggest
unusu
capac
merscov
infect
cell
induc
apoptosi
might
contribut
high
pathogen
viru
role
cell
control
pathogenesi
sarscov
infect
remain
incomplet
understood
mous
studi
observ
deplet
cell
result
enhanc
interstiti
pneumon
delay
clearanc
sarscov
lung
tissu
associ
reduc
product
neutral
antibodi
cytokin
well
reduc
pulmonari
recruit
lymphocyt
receptor
merscov
identifi
exopeptidas
dipeptidyl
peptidas
role
main
determin
host
tropism
merscov
elucid
sever
studi
commonli
use
laboratori
anim
speci
syrian
hamster
mice
ferret
suscept
merscov
sinc
ortholog
anim
speci
unabl
bind
merscov
spike
protein
mediat
viru
entri
merscov
inocul
rabbit
display
asymptomat
infect
neither
signific
histopatholog
chang
clinic
symptom
observ
rabbit
although
viru
could
detect
lung
tissu
camel
suscept
merscov
isol
human
although
infect
camel
shed
larg
amount
viru
upper
respiratori
tract
diseas
sign
mild
among
experiment
anim
test
develop
mer
anim
model
rhesu
macaqu
develop
mild
moder
respiratori
infect
wherea
common
marmoset
display
moder
sever
respiratori
diseas
inocul
use
combin
rout
intranas
intratrach
oral
ocular
marmoset
merscov
infect
suggest
dissemin
infect
sinc
viral
rna
detect
nearli
test
tissu
infect
anim
includ
blood
kidney
intestin
liver
spleen
etc
howev
except
sampl
respiratori
tract
isol
infecti
viru
organ
success
interestingli
suscept
macrophag
merscov
evidenc
vitro
ex
vivo
studi
verifi
alveolar
macrophag
merscov
infect
marmoset
first
mer
mous
model
gener
prior
transduct
adenovir
vector
express
human
mice
display
transient
viral
pneumonia
resolv
within
week
infect
sever
line
human
transgen
mice
subsequ
report
merscov
infect
replic
invari
evidenc
transgen
mice
howev
diseas
sign
patholog
mice
differ
appear
depend
promot
control
express
gene
pascal
et
al
replac
mous
orf
human
knockedin
control
endogen
mous
promot
author
believ
strategi
may
render
express
physiologicallyrelev
context
viru
inocul
mice
merscov
robustli
replic
mous
lung
howev
inocul
mice
exhibit
diseas
sign
without
extrapulmonari
involv
hand
two
line
transgen
mice
transgen
control
chicken
promot
cytokeratin
promot
respect
highli
permiss
merscov
infect
mice
develop
progress
pneumonia
fatal
outcom
intranas
inocul
infecti
viru
constantli
exclus
recov
lung
brain
tissu
similar
marmoset
studi
viral
rna
also
detect
extrapulmonari
organ
includ
heart
spleen
intestin
viru
isol
organ
unsuccess
transgen
mous
cytokeratin
promot
gener
parallel
anoth
transgen
mous
line
surfact
protein
c
spc
promot
spc
promot
confer
transgen
express
bronchiolar
alveolar
epithelia
promot
drive
univers
transgen
express
epithelia
liver
kidney
gastrointestin
tract
cell
nervou
system
apart
respiratori
tract
mice
promot
develop
lethal
infect
intranas
inocul
merscov
contrast
inocul
mice
spc
promot
caus
mortal
bodi
weight
loss
therefor
morbid
mortal
human
transgen
mice
may
correl
tissuecellular
distribut
andor
express
intens
transgen
notabl
common
discoveri
among
merscov
suscept
anim
gene
express
antivir
cytokin
proinflammatori
cytokin
chemokin
elev
collect
tissu
tropism
merscov
human
host
fulli
elucid
although
accumul
evid
possibl
extrapulmonari
involv
mer
patient
undoubtedli
transgen
mous
studi
conduc
develop
antivir
vaccin
merscov
howev
term
implic
pathogenesi
human
mer
find
transgen
mice
must
interpret
great
caution
indepth
investig
tissu
tropism
merscov
human
host
facilit
understand
toward
transmiss
rout
pathogenesi
mer
merscov
mous
model
util
test
efficaci
antivir
drug
neutral
antibodi
vaccin
venezuelan
equin
enceph
replic
particl
express
merscov
spike
protein
vrp
demonstr
substanti
reduc
viru
titer
lung
tissu
immun
transduc
mous
model
group
subsequ
examin
vrp
permiss
transgen
mous
model
vrp
immun
transgen
mice
complet
protect
lethal
infect
pretreat
serum
mous
immun
vrp
also
protect
fatal
infect
two
fulli
human
neutral
antibodi
bind
distinct
epitop
mer
spike
protein
gener
use
mous
express
human
antibodi
display
pre
postexposur
protect
efficaci
merscov
infect
transgen
mice
pathogenesi
human
merscov
infect
remain
poorli
understood
human
respiratori
epithelium
highli
suscept
merscov
support
product
viral
replic
howev
merscov
evolv
multipl
antagonist
mechan
attenu
induct
antivir
proinflammatori
cytokin
affect
epitheli
cell
addit
merscov
readili
infect
robustli
replic
human
macrophag
dendrit
cell
elicit
aberr
product
proinflammatori
cytokineschemokin
merscov
also
effect
infect
human
primari
cell
induc
massiv
apoptosi
cell
although
clinic
present
well
vitro
ex
vivo
studi
implic
potenti
viru
dissemin
upon
merscov
infect
extrapulmonari
involv
ascertain
merscov
permiss
anim
model
viral
rna
detect
multipl
organ
infect
anim
howev
recoveri
infecti
viru
unsuccess
extrapulmonari
organ
studi
warrant
character
tissu
tropism
merscov
better
understand
toward
pathogenesi
mer
